Skip to content

Opening book details…

About this Medicine article

Clinical impact of interruption in adjuvant Trastuzumab therapy in patients with operable HER-2 positive breast cancer by Sardesai, Sagar; Sukumar, Jasmine; Kassem, Mahmoud; Palettas, Marilly; Stephens, Julie; Morgan, Evan; Addison, Daniel; Baliga, Ragavendra; Stover, Daniel G.; VanDeusen, Jeffrey; Williams, Nicole; Cherian, Mathew; Lustberg, Maryam; Wesolowski, Robert; Ramaswamy, Bhuvaneswari is a Medicine article available to read on EtoBox.

It is typically read by researchers, students, and practitioners in Medicine.

Author
Sardesai, Sagar; Sukumar, Jasmine; Kassem, Mahmoud; Palettas, Marilly; Stephens, Julie; Morgan, Evan; Addison, Daniel; Baliga, Ragavendra; Stover, Daniel G.; VanDeusen, Jeffrey; Williams, Nicole; Cherian, Mathew; Lustberg, Maryam; Wesolowski, Robert; Ramaswamy, Bhuvaneswari
Publisher
Springer (Biomed Central Ltd.); London: BioMed Central, 2015-; Springer Science and Business Media LLC (ISSN 2057-3804)
Published
2020
Field
Medicine (Health Sciences)

More by Sardesai, Sagar; Sukumar, Jasmine; Kassem, Mahmoud; Palettas, Marilly; Stephens, Julie; Morgan, Evan; Addison, Daniel; Baliga, Ragavendra; Stover, Daniel G.; VanDeusen, Jeffrey; Williams, Nicole; Cherian, Mathew; Lustberg, Maryam; Wesolowski, Robert; Ramaswamy, Bhuvaneswari

Browse all works by Sardesai, Sagar; Sukumar, Jasmine; Kassem, Mahmoud; Palettas, Marilly; Stephens, Julie; Morgan, Evan; Addison, Daniel; Baliga, Ragavendra; Stover, Daniel G.; VanDeusen, Jeffrey; Williams, Nicole; Cherian, Mathew; Lustberg, Maryam; Wesolowski, Robert; Ramaswamy, Bhuvaneswari